0 TSX News - December 2, 2024Renforth Advancing Globex’s Parbec Gold Royalty PropertyROUYN-NORANDA, Quebec, Dec. 02, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, […]Read More
0 TSX News - December 2, 2024CEMATRIX Announces Randy Boomhour as President and CEOCALGARY, Alberta, Dec. 02, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a North […]Read More
0 TSX News - December 2, 2024CEMATRIX Announces the Retirement of Jeff KendrickCALGARY, Alberta, Dec. 02, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company”) a North American […]Read More
0 TSX News - December 2, 2024Spectral Medical Provides November Tigris Trial Update• 136 patients enrolled • Company to host Tigris Trial Update Call December 16, 2024 TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) […]Read More
0 TSX News - December 2, 2024CAPREIT Announces $313 Million of Capital Deployment In NovemberThis news release constitutes a “designated news release” for the purposes of CAPREIT’s prospectus supplement dated February 22, 2024, to […]Read More
0 TSX News - December 2, 2024Sernova Update on Strategic InitiativesSigned Letter of Intent with ‘Project REEM Ventures’ for Product Development and Commercialization in the Kingdom of Saudi Arabia Renowned […]Read More
0 TSX News - December 2, 2024ISC Issues Reminder About Ticker Symbol Change From “ISV” to “ISC” On the Toronto Stock ExchangeREGINA, Saskatchewan, Dec. 02, 2024 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISC) (“ISC” or the “Company”) would like to remind […]Read More
0 TSX News - December 2, 2024BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast CancerThe Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of […]Read More
0 TSX News - December 2, 2024Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical CompanyTORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a […]Read More
0 TSX News - December 2, 2024Theratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement QuébecNew financing replaces existing credit facility to optimize Company’s capital structure Favorable interest rates and amortization schedules to free up […]Read More